EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

ACT on Vaping: Pilot Randomized Controlled Trial of a Novel Digital Health App With Text Messaging for Young Adult Vaping Cessation

Jaimee L Heffner iD, Kelsey Baker, Katerina Georgiou, Amanda L Graham iD, Megan M Kelly, Pinelopi Konstantinou, Eleana Lamprou, Chinmaya Lele, Kathleen Z Lok, Maria Orzechowski, Raymond A Ruiz iD, Edit Serfozo und 1 weitere

Nicotine and Tobacco Research · 2026

DOI: 10.1093/ntr/ntaf112 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, 2026. Verfasst von Jaimee L Heffner und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center, Seattle, WA, USA. Hauptthemen laut MEDLINE: Text Messaging, Vaping, Mobile Applications, Smoking Cessation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is no published evidence to support the efficacy of any digital vaping cessation program for young adults (YAs) at differing levels of readiness to quit. In this pilot randomized controlled trial, we evaluated the preliminary acceptability and efficacy of a program for vaping cessation based on acceptance and commitment therapy (ACT on Vaping), delivered via a smartphone app and text messaging.

Methods

YAs aged 18–30 (n = 61) were randomized 1:1 to ACT on Vaping (n = 31) or incentivized text message control (n = 30). Outcome data were collected at 3 months post-randomization. Results were compared against a priori benchmarks for acceptability (satisfaction of ≥3.5 on 5-point scale) and efficacy relative to control (meeting at least one of three): ≥1-point difference in Contemplation Ladder change scores; ≥5 percentage difference in 24-hour quit attempts, ≥5 percentage difference in cotinine-confirmed 30-day point prevalence abstinence (PPA) from all non-therapeutic nicotine/tobacco.

Results

Satisfaction with ACT on Vaping averaged 3.8, exceeding the acceptability benchmark. A higher proportion of participants in the ACT on Vaping arm reported a 24-hour quit attempt (87.5% vs. 75.9%), exceeding the efficacy benchmark. Both changes in quit readiness (+0.96 in ACT on Vaping vs. +0.72 in control) and cotinine-confirmed 30-day PPA (4.2% in ACT on Vaping vs. 0% in control) were descriptively higher for ACT on Vaping but did not reach the benchmark level for efficacy.

Conclusions

ACT on Vaping had promising acceptability and preliminary efficacy. A fully powered trial of ACT on Vaping is warranted to evaluate its efficacy.

Implications

Digital interventions are a promising yet under-researched approach for reaching and supporting YAs to quit vaping. This proof-of-concept pilot randomized controlled trial evaluated a novel mobile health application and associated text messaging program (ACT on Vaping) for young adult vaping cessation and found preliminary evidence for acceptability and efficacy relative to an incentivized text message control arm, warranting evaluation in a fully powered trial as a next step.

Trial registration

NCT05897242

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Text MessagingVapingMobile ApplicationsSmoking CessationAcceptance and Commitment TherapyHumansPilot ProjectsFemaleAdultMaleYoung AdultAdolescentDigital Health

Autor:innen und Institutionen

  • Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • University of Cyprus, Nicosia, Cyprus.
  • Innovations Center, Truth Initiative, Washington, DC, USA.
  • University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Cyprus University of Technology, Limassol, Cyprus.
  • UCLan Cyprus, Larnaca, Cyprus.

ORCID-Profile: Jaimee L Heffner, Amanda L Graham, Raymond A Ruiz

Förderung

  • NCI NIH HHS
  • NIDA NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Institute on Drug Abuse

Zitieren

APA

Heffner, J. L., Baker, K., Georgiou, K., Graham, A. L., Kelly, M. M., Konstantinou, P., Lamprou, E., Lele, C., Lok, K. Z., Orzechowski, M., Ruiz, R. A., Serfozo, E., & Karekla, M. (2026). ACT on Vaping: Pilot Randomized Controlled Trial of a Novel Digital Health App With Text Messaging for Young Adult Vaping Cessation. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntaf112

Vancouver

Heffner JL, Baker K, Georgiou K, Graham AL, Kelly MM, Konstantinou P, et al. ACT on Vaping: Pilot Randomized Controlled Trial of a Novel Digital Health App With Text Messaging for Young Adult Vaping Cessation. Nicotine and Tobacco Research. 2026. doi:10.1093/ntr/ntaf112

BibTeX
@article{Heffner2026,
  author = {Heffner, Jaimee L and Baker, Kelsey and Georgiou, Katerina and Graham, Amanda L and Kelly, Megan M and Konstantinou, Pinelopi and Lamprou, Eleana and Lele, Chinmaya and Lok, Kathleen Z and Orzechowski, Maria and Ruiz, Raymond A and Serfozo, Edit and Karekla, Maria},
  title = {ACT on Vaping: Pilot Randomized Controlled Trial of a Novel Digital Health App With Text Messaging for Young Adult Vaping Cessation},
  journal = {Nicotine and Tobacco Research},
  year = {2026},
  doi = {10.1093/ntr/ntaf112}
}
Kostenlos starten →